Review
Open access
Oct 2026
N-Acetylcysteine in Schizophrenia: A Convergent Redox-Based Approach to Therapeutic Potential
Schizophrenia (SCZ) remains one of the most disabling psychiatric disorders, in large part because current antipsychotics (APs) inadequately address negative symptoms and cognitive deficits. Converging evidence implicates a set of interconnected mechanisms, NMDAR hypofunction, oxidative stress, and a possible low-grade...
Enric Rubio-Contreras, Alonso Pérez-Toribio, P. Álvaro et al.
· Antioxidants · 0 citations